Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SPRB Spruce Biosciences, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $48.58 +2.8% | $15.79 -3.2% |
| StockIQ Score | 47D+ Moderate Risk: Medium | 42D Weak Risk: Medium |
| Technical | 19F | 36F |
| Fundamental | 45D+ | 35F |
| Growth | 60C+ | 50C- |
| Fair Value | 55C | 38F |
| News | 86A | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Spruce Biosciences (SPRB) outperforms Ascentage Pharma (AAPG) in most categories. Its investor score (47 vs. 42) and overall rating (Moderate vs. Weak) are stronger. SPRB also leads in technical (19 vs. 36) and fundamental scores (45 vs. 35), though AAPG has slightly higher growth (50 vs. 60) and valuation (38 vs. 55) scores. SPRB’s growth and valuation scores are notably higher.
